Neogen (NEOG) Return on Capital Employed Growth (1y) (2012 - 2026)
Neogen (NEOG) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 216.00 |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 2,696.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2,696.00 |
| Feb 28, 2026 | 41,258.00 |
| Nov 30, 2025 | 262.00 |
| Aug 31, 2025 | -3,406.00 |
| May 31, 2025 | -6,302.00 |
| Feb 28, 2025 | -43,395.00 |
| Nov 30, 2024 | -2,374.00 |
| Aug 31, 2024 | -14.00 |
| May 31, 2024 | 47.00 |
| Feb 29, 2024 | 83.00 |
| Nov 30, 2023 | 78.00 |
| Aug 31, 2023 | -353.00 |
| May 31, 2023 | -559.00 |
| Feb 28, 2023 | -597.00 |
| Nov 30, 2022 | -704.00 |
| Aug 31, 2022 | -412.00 |
| May 31, 2022 | 15.00 |
| Feb 28, 2022 | 21.00 |
| Nov 30, 2021 | 154.00 |
| Aug 31, 2021 | 234.00 |